2008
DOI: 10.1016/j.jaut.2007.09.003
|View full text |Cite
|
Sign up to set email alerts
|

Desiccating environmental stress exacerbates autoimmune lacrimal keratoconjunctivitis in non-obese diabetic mice

Abstract: The non-obese diabetic (NOD) mouse is prone to develop autoimmune disease, including Sjögren's syndrome. The purpose of this study was to determine if desiccating environmental stress exacerbates the development of Sjögren's syndrome-like lacrimal keratoconjunctivitis in the NOD.B10.H2 b mouse. Four-week-old male mice were used as young controls. Sixteen-week-old male mice were untreated or subjected to desiccating stress with a fan alone or with a fan plus subcutaneous injections of the anticholinergic agent … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
31
0

Year Published

2008
2008
2023
2023

Publication Types

Select...
7
2

Relationship

2
7

Authors

Journals

citations
Cited by 44 publications
(33 citation statements)
references
References 37 publications
2
31
0
Order By: Relevance
“…However, NOD.B10-H2 b do not develop type I diabetes. (32,50) Our previous published studies (13) and figure 2 show that C57BL/6 mice have the same disease phenotype that naturally occurs with age, however NOD.B10.H2 b develop disease sooner, making this a useful model for aging studies.…”
Section: Discussionmentioning
confidence: 90%
See 1 more Smart Citation
“…However, NOD.B10-H2 b do not develop type I diabetes. (32,50) Our previous published studies (13) and figure 2 show that C57BL/6 mice have the same disease phenotype that naturally occurs with age, however NOD.B10.H2 b develop disease sooner, making this a useful model for aging studies.…”
Section: Discussionmentioning
confidence: 90%
“…These mice fail to develop insulitis and type 1 diabetes, but continue to show a mild SS-like disease. (32)…”
Section: Introductionmentioning
confidence: 99%
“…We induced EDE by subcutaneous injection of 0.5 mg/0.2 mL scopolamine hydrobromide (Sigma-Aldrich Corp.) four times a day (8 AM, 11 AM, 2 PM, and 5 PM) with exposure to an air draft and 30% ambient humidity, as described previously. 32,33 During the experiments animal behavior, and food and water intake were not restricted.…”
Section: Mouse Model Of Dry Eye and Experimental Designmentioning
confidence: 99%
“…Experimental dry eye (EDE) was induced by subcutaneous injection of 0.5 mg/0.2 mL scopolamine hydrobromide (SigmaAldrich, St. Louis, MO) four times a day (8 AM, 11 AM, 2 PM, and 5 PM) with exposure to an air draft and 30% ambient humidity, as previously described. [26][27][28][29] During these experiments, the animals' behavior, food, and water intake were not restricted.…”
Section: Mouse Model Of Dry Eye and Experimental Proceduresmentioning
confidence: 99%